Careers  |  Sign In  |  Register  |   Twitter

Latest in Oncology

Reuters Health • The Doctor's Channel Daily Newscast

Timing of Trastuzumab Administration Does Not Affect Benefit in Breast cancer

NEW YORK (Reuters Health) – In the neoadjuvant treatment of HER2-positive breast cancer, administering trastuzumab concurrently with anthracyclines offers no advantage over sequential administration, according to the results of a new multicenter trial. The researchers compared the two approaches to...

Reuters Health • The Doctor's Channel Daily Newscast

Platinum-Combination Chemotherapy Improves Survival in Recurrent Ovarian Cancer

NEW YORK (Reuters Health) – Compared to single-agent platinum chemotherapy, platinum-combination chemotherapy improves survival in patients with recurrence of ovarian cancer, a meta-analysis has shown. The researchers say the results provide “the strongest evidence to date that combination therapy...

Reuters Health • The Doctor's Channel Daily Newscast

Breast Cancer Recurrence Higher with Intraoperative Radiotherapy than External RT

NEW YORK (Reuters Health) – Results of a randomized trial conducted in Italy indicate that conventional external radiotherapy (RT) after breast conserving surgery for early breast cancer is more effective than intraoperative radiotherapy in controlling disease recurrence. Nonetheless, “Overall...